S Wiggins, P Whyte, M Huggins, S Adam, J Theilmann, M Bloch, S B Sheps, M T Schechter, M R Hayden. N Engl J Med 1992
Times Cited: 345
Times Cited: 345
Times Cited
Times Co-cited
Similarity
Psychological costs and benefits of predictive testing for Huntington's disease.
A M Codori, J Brandt. Am J Med Genet 1994
A M Codori, J Brandt. Am J Med Genet 1994
25
Psychological consequences of predictive genetic testing: a systematic review.
M Broadstock, S Michie, T Marteau. Eur J Hum Genet 2000
M Broadstock, S Michie, T Marteau. Eur J Hum Genet 2000
23
A worldwide assessment of the frequency of suicide, suicide attempts, or psychiatric hospitalization after predictive testing for Huntington disease.
E W Almqvist, M Bloch, R Brinkman, D Craufurd, M R Hayden. Am J Hum Genet 1999
E W Almqvist, M Bloch, R Brinkman, D Craufurd, M R Hayden. Am J Hum Genet 1999
23
Prediction of psychological functioning one year after the predictive test for Huntington's disease and impact of the test result on reproductive decision making.
M Decruyenaere, G Evers-Kiebooms, A Boogaerts, J J Cassiman, T Cloostermans, K Demyttenaere, R Dom, J P Fryns, H Van den Berghe. J Med Genet 1996
M Decruyenaere, G Evers-Kiebooms, A Boogaerts, J J Cassiman, T Cloostermans, K Demyttenaere, R Dom, J P Fryns, H Van den Berghe. J Med Genet 1996
20
Predictive testing for Huntington disease in Canada: adverse effects and unexpected results in those receiving a decreased risk.
M Huggins, M Bloch, S Wiggins, S Adam, O Suchowersky, M Trew, M Klimek, C R Greenberg, M Eleff, L P Thompson. Am J Med Genet 1992
M Huggins, M Bloch, S Wiggins, S Adam, O Suchowersky, M Trew, M Klimek, C R Greenberg, M Eleff, L P Thompson. Am J Med Genet 1992
19
Psychological consequences and predictors of adverse events in the first 5 years after predictive testing for Huntington's disease.
E W Almqvist, R R Brinkman, S Wiggins, M R Hayden. Clin Genet 2003
E W Almqvist, R R Brinkman, S Wiggins, M R Hayden. Clin Genet 2003
20
Psychological impact of genetic testing for Huntington's disease: an update of the literature.
B Meiser, S Dunn. J Neurol Neurosurg Psychiatry 2000
B Meiser, S Dunn. J Neurol Neurosurg Psychiatry 2000
17
Psychological distress in the 5-year period after predictive testing for Huntington's disease.
Marleen Decruyenaere, Gerry Evers-Kiebooms, Trees Cloostermans, Andrea Boogaerts, Koen Demyttenaere, René Dom, Jean Pierre Fryns. Eur J Hum Genet 2003
Marleen Decruyenaere, Gerry Evers-Kiebooms, Trees Cloostermans, Andrea Boogaerts, Koen Demyttenaere, René Dom, Jean Pierre Fryns. Eur J Hum Genet 2003
20
Three-year follow-up after presymptomatic testing for Huntington's disease in tested individuals and partners.
A Tibben, R Timman, E C Bannink, H J Duivenvoorden. Health Psychol 1997
A Tibben, R Timman, E C Bannink, H J Duivenvoorden. Health Psychol 1997
16
16
Predictive testing for Huntington disease in Canada: the experience of those receiving an increased risk.
M Bloch, S Adam, S Wiggins, M Huggins, M R Hayden. Am J Med Genet 1992
M Bloch, S Adam, S Wiggins, M Huggins, M R Hayden. Am J Med Genet 1992
16
13
Predictors of psychological adjustment to genetic testing for Huntington's disease.
A M Codori, P R Slavney, C Young, D L Miglioretti, J Brandt. Health Psychol 1997
A M Codori, P R Slavney, C Young, D L Miglioretti, J Brandt. Health Psychol 1997
20
Self-selection in predictive testing for Huntington's disease.
A M Codori, R Hanson, J Brandt. Am J Med Genet 1994
A M Codori, R Hanson, J Brandt. Am J Med Genet 1994
12
Presymptomatic diagnosis of delayed-onset disease with linked DNA markers. The experience in Huntington's disease.
J Brandt, K A Quaid, S E Folstein, P Garber, N E Maestri, M H Abbott, P R Slavney, M L Franz, L Kasch, H H Kazazian. JAMA 1989
J Brandt, K A Quaid, S E Folstein, P Garber, N E Maestri, M H Abbott, P R Slavney, M L Franz, L Kasch, H H Kazazian. JAMA 1989
12
A polymorphic DNA marker genetically linked to Huntington's disease.
J F Gusella, N S Wexler, P M Conneally, S L Naylor, M A Anderson, R E Tanzi, P C Watkins, K Ottina, M R Wallace, A Y Sakaguchi. Nature 1983
J F Gusella, N S Wexler, P M Conneally, S L Naylor, M A Anderson, R E Tanzi, P C Watkins, K Ottina, M R Wallace, A Y Sakaguchi. Nature 1983
12
12
BRCA1 testing in families with hereditary breast-ovarian cancer. A prospective study of patient decision making and outcomes.
C Lerman, S Narod, K Schulman, C Hughes, A Gomez-Caminero, G Bonney, K Gold, B Trock, D Main, J Lynch,[...]. JAMA 1996
C Lerman, S Narod, K Schulman, C Hughes, A Gomez-Caminero, G Bonney, K Gold, B Trock, D Main, J Lynch,[...]. JAMA 1996
12
Adverse psychological events occurring in the first year after predictive testing for Huntington's disease. The Canadian Collaborative Study Predictive Testing.
K Lawson, S Wiggins, T Green, S Adam, M Bloch, M R Hayden. J Med Genet 1996
K Lawson, S Wiggins, T Green, S Adam, M Bloch, M R Hayden. J Med Genet 1996
19
Adverse effects of predictive testing for Huntington disease underestimated: long-term effects 7-10 years after the test.
Reinier Timman, Raymund Roos, Anneke Maat-Kievit, Aad Tibben. Health Psychol 2004
Reinier Timman, Raymund Roos, Anneke Maat-Kievit, Aad Tibben. Health Psychol 2004
16
Attitudes of persons at risk for Huntington disease toward predictive testing.
S Kessler, T Field, L Worth, H Mosbarger. Am J Med Genet 1987
S Kessler, T Field, L Worth, H Mosbarger. Am J Med Genet 1987
11
17
Uptake of presymptomatic predictive testing for Huntington's disease.
D Craufurd, A Dodge, L Kerzin-Storrar, R Harris. Lancet 1989
D Craufurd, A Dodge, L Kerzin-Storrar, R Harris. Lancet 1989
10
Attitudes toward direct predictive testing for the Huntington disease gene. Relevance for other adult-onset disorders. The Canadian Collaborative Group on Predictive Testing for Huntington Disease.
R Babul, S Adam, B Kremer, S Dufrasne, S Wiggins, M Huggins, J Theilmann, M Bloch, M R Hayden. JAMA 1993
R Babul, S Adam, B Kremer, S Dufrasne, S Wiggins, M Huggins, J Theilmann, M Bloch, M R Hayden. JAMA 1993
16
Predictive testing for Huntington disease: II. Demographic characteristics, life-style patterns, attitudes, and psychosocial assessments of the first fifty-one test candidates.
M Bloch, M Fahy, S Fox, M R Hayden. Am J Med Genet 1989
M Bloch, M Fahy, S Fox, M R Hayden. Am J Med Genet 1989
10
Predictive testing for Huntington disease: nonparticipants compared with participants in the Dutch program.
I M van der Steenstraten, A Tibben, R A Roos, J J van de Kamp, M F Niermeijer. Am J Hum Genet 1994
I M van der Steenstraten, A Tibben, R A Roos, J J van de Kamp, M F Niermeijer. Am J Hum Genet 1994
9
Predictive testing for Huntington disease: I. Description of a pilot project in British Columbia.
S Fox, M Bloch, M Fahy, M R Hayden. Am J Med Genet 1989
S Fox, M Bloch, M Fahy, M R Hayden. Am J Med Genet 1989
9
Presymptomatic testing in Huntington's disease and autosomal dominant cerebellar ataxias.
C Goizet, G Lesca, A Dürr. Neurology 2002
C Goizet, G Lesca, A Dürr. Neurology 2002
13
The psychological complexity of predictive testing for late onset neurogenetic diseases and hereditary cancers: implications for multidisciplinary counselling and for genetic education.
G Evers-Kiebooms, M Welkenhuysen, E Claes, M Decruyenaere, L Denayer. Soc Sci Med 2000
G Evers-Kiebooms, M Welkenhuysen, E Claes, M Decruyenaere, L Denayer. Soc Sci Med 2000
13
Psychological studies in Huntington's disease: making up the balance.
M Duisterhof, R W Trijsburg, M F Niermeijer, R A Roos, A Tibben. J Med Genet 2001
M Duisterhof, R W Trijsburg, M F Niermeijer, R A Roos, A Tibben. J Med Genet 2001
21
Impact of Event Scale: a measure of subjective stress.
M Horowitz, N Wilner, W Alvarez. Psychosom Med 1979
M Horowitz, N Wilner, W Alvarez. Psychosom Med 1979
9
Psychological responses to BRCA1 mutation testing: preliminary findings.
R T Croyle, K R Smith, J R Botkin, B Baty, J Nash. Health Psychol 1997
R T Croyle, K R Smith, J R Botkin, B Baty, J Nash. Health Psychol 1997
9
Reluctance to undergo predictive testing: the case of Huntington disease.
K A Quaid, M Morris. Am J Med Genet 1993
K A Quaid, M Morris. Am J Med Genet 1993
8
Attitudes toward presymptomatic testing in Huntington disease.
C Mastromauro, R H Myers, B Berkman. Am J Med Genet 1987
C Mastromauro, R H Myers, B Berkman. Am J Med Genet 1987
8
Predictive testing for Huntington's disease with use of a linked DNA marker.
G J Meissen, R H Myers, C A Mastromauro, W J Koroshetz, K W Klinger, L A Farrer, P A Watkins, J F Gusella, E D Bird, J B Martin. N Engl J Med 1988
G J Meissen, R H Myers, C A Mastromauro, W J Koroshetz, K W Klinger, L A Farrer, P A Watkins, J F Gusella, E D Bird, J B Martin. N Engl J Med 1988
8
Ten years of presymptomatic testing for Huntington's disease: the experience of the UK Huntington's Disease Prediction Consortium.
P S Harper, C Lim, D Craufurd. J Med Genet 2000
P S Harper, C Lim, D Craufurd. J Med Genet 2000
8
Predicting adaptation to presymptomatic DNA testing for late onset disorders: who will experience distress? Rotterdam Leiden Genetics Workgroup.
A C DudokdeWit, A Tibben, H J Duivenvoorden, M F Niermeijer, J Passchier. J Med Genet 1998
A C DudokdeWit, A Tibben, H J Duivenvoorden, M F Niermeijer, J Passchier. J Med Genet 1998
10
What you don't know can hurt you: adverse psychologic effects in members of BRCA1-linked and BRCA2-linked families who decline genetic testing.
C Lerman, C Hughes, S J Lemon, D Main, C Snyder, C Durham, S Narod, H T Lynch. J Clin Oncol 1998
C Lerman, C Hughes, S J Lemon, D Main, C Snyder, C Durham, S Narod, H T Lynch. J Clin Oncol 1998
8
Psychological effects of presymptomatic DNA testing for Huntington's disease in the Dutch program.
A Tibben, H J Duivenvoorden, M F Niermeijer, M Vegter-van der Vlis, R A Roos, F Verhage. Psychosom Med 1994
A Tibben, H J Duivenvoorden, M F Niermeijer, M Vegter-van der Vlis, R A Roos, F Verhage. Psychosom Med 1994
13
Reactions to predictive testing in Huntington disease: case reports of coping with a new genetic status.
T B Wahlin, A Lundin, L Bäckman, E Almqvist, A Haegermark, B Winblad, M Anvret. Am J Med Genet 1997
T B Wahlin, A Lundin, L Bäckman, E Almqvist, A Haegermark, B Winblad, M Anvret. Am J Med Genet 1997
33
Predictive, pre-natal and diagnostic genetic testing for Huntington's disease: the experience in Canada from 1987 to 2000.
S Creighton, E W Almqvist, D MacGregor, B Fernandez, H Hogg, J Beis, J P Welch, C Riddell, R Lokkesmoe, M Khalifa,[...]. Clin Genet 2003
S Creighton, E W Almqvist, D MacGregor, B Fernandez, H Hogg, J Beis, J P Welch, C Riddell, R Lokkesmoe, M Khalifa,[...]. Clin Genet 2003
8
Predictive testing for Huntington's disease: a challenge for persons at risk and for professionals.
G Evers-Kiebooms, M Decruyenaere. Patient Educ Couns 1998
G Evers-Kiebooms, M Decruyenaere. Patient Educ Couns 1998
11
Impact of DNA testing for early-onset familial Alzheimer disease and frontotemporal dementia.
E J Steinbart, C O Smith, P Poorkaj, T D Bird. Arch Neurol 2001
E J Steinbart, C O Smith, P Poorkaj, T D Bird. Arch Neurol 2001
9
Impact of genetic testing for Huntington disease on the family system.
S K Sobel, D B Cowan. Am J Med Genet 2000
S K Sobel, D B Cowan. Am J Med Genet 2000
7
The genetic testing of children. Working Party of the Clinical Genetics Society (UK)
A Clarke. J Med Genet 1994
A Clarke. J Med Genet 1994
7
Predictive testing for Huntington's disease: risk perception, reasons for testing and psychological profile of test applicants.
M Decruyenaere, G Evers-Kiebooms, A Boogaerts, J J Cassiman, T Cloostermans, K Demyttenaere, R Dom, J P Fryns, H Van den Berghe. Genet Couns 1995
M Decruyenaere, G Evers-Kiebooms, A Boogaerts, J J Cassiman, T Cloostermans, K Demyttenaere, R Dom, J P Fryns, H Van den Berghe. Genet Couns 1995
10
19
Five year study of prenatal testing for Huntington's disease: demand, attitudes, and psychological assessment.
S Adam, S Wiggins, P Whyte, M Bloch, M H Shokeir, H Soltan, W Meschino, A Summers, O Suchowersky, J P Welch. J Med Genet 1993
S Adam, S Wiggins, P Whyte, M Bloch, M H Shokeir, H Soltan, W Meschino, A Summers, O Suchowersky, J P Welch. J Med Genet 1993
9
Presymptomatic DNA testing for Huntington disease: identifying the need for psychological intervention.
A Tibben, H J Duivenvoorden, M Vegter-van der Vlis, M F Niermeijer, P G Frets, J J van de Kamp, R A Roos, H G Rooijmans, F Verhage. Am J Med Genet 1993
A Tibben, H J Duivenvoorden, M Vegter-van der Vlis, M F Niermeijer, P G Frets, J J van de Kamp, R A Roos, H G Rooijmans, F Verhage. Am J Med Genet 1993
9
An inventory for measuring depression.
A T BECK, C H WARD, M MENDELSON, J MOCK, J ERBAUGH. Arch Gen Psychiatry 1961
A T BECK, C H WARD, M MENDELSON, J MOCK, J ERBAUGH. Arch Gen Psychiatry 1961
7
Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.